MGI Tech Co

MGI Tech Co Retained Earnings

The Retained Earnings of MGI Tech Co (688114.SS) as of Oct 25, 2026 is -1.28 B CNY. In the previous year, Retained Earnings was -1.06 B CNY — a change of 20.91% (lower).

Retained Earnings

-1.28 BCNY

YoY

20.91%

Last updated:

Retained Earnings of MGI Tech Co is 2025 -1.28 B CNY. Retained Earnings of MGI Tech Co was 2024 -1.06 B CNY. It decreases by 20.91% lower compared to the previous year.

The MGI Tech Co Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2020
-2.18 B CNY
Jan 1, 2021
-1.73 B CNY
Jan 1, 2022
295.69 M CNY
Jan 1, 2023
-461.44 M CNY
Jan 1, 2024
-1.06 B CNY
Jan 1, 2025
-1.28 B CNY
The MGI Tech Co Retained Earnings history
YEARRetained EarningsYoY
-1.28 BCNY+20.91%
-1.06 BCNY+130.21%
-461.44 MCNY-256.05%
295.69 MCNY-117.08%
-1.73 BCNY-20.77%
-2.18 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MGI Tech Co Stock analysis

What does MGI Tech Co do? MGI Tech Co., Ltd. generates revenue through the sale of DNA sequencing instruments, reagents, and related products for life science research, agriculture, precision medicine, and healthcare. The company's gene sequencer business offers desktop and large sequencers, creating a multi-model product range for diverse user needs. Laboratory automation products include automated sample processing systems, pipelines, and reagent consumables, targeting laboratories requiring efficient workflows. New business segments feature cytomic solutions, remote ultrasound robots, and bioinformation Technology (BIT) products, expanding into emerging applications. The primary customers are research institutions, agricultural companies, healthcare providers, and precision medicine facilities. These segments purchase the company's instruments, reagents, and automation systems to support their operations in genomics, diagnostics, and laboratory management. The gene sequencer and laboratory automation businesses form the core revenue streams, while new business products represent growth opportunities in innovative fields. MGI Tech's product portfolio spans multiple applications, with the gene sequencer business focusing on scalable sequencing solutions and laboratory automation addressing workflow efficiency. The new business segment introduces advanced technologies like remote ultrasound robots, targeting specialized healthcare environments. All products are sold directly to end-users in the specified sectors without mentioning third-party distributors or partners. MGI Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MGI Tech Co stock

Retained Earnings of MGI Tech Co is -1.28 B CNY in 2025.

Retained Earnings of MGI Tech Co changed from -1.06 B CNY to -1.28 B CNY, representing a 20.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings MGI Tech Co since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's MGI Tech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — MGI Tech Co

All Key Metrics — MGI Tech Co